Aug 16, 2022 / 12:00PM GMT
Operator
Good afternoon, everyone. Welcome to our conference call held in connection with our interim report for 2022, which we released this morning. It's clearly been a very busy morning in Hearing Aids. Now it's our turn to walk you through a brief presentation, and then we'll turn it over to Q&A afterwards.
The slides can also be found on our website. And as usual, we plan for this call to last no more than 1 hour, including the Q&A.
We have President and CEO, and Søren Nielsen; CFO, René Schneider; and the IR team, Peter Pudselykke; and myself, Mathias Holten Møller, on the call today. And Søren, it's all yours.
Søren Nielsen - Demant A/S-CEO - President & Member of Executive Board
Yes. Thank you, Mathias. And welcome, everybody. The agenda for today's session is key events and financial takeaways, update on hearing health care, update on communication, and we will take you through a financial review. I'll comment on the outlook, and then we'll quickly go to Q&A.
Q2 2022 Demant A/S Earnings Call Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers